Cancer Risk in Type 2 Diabetes Mellitus: Metabolic Links and Therapeutic Considerations
2011

Cancer Risk in Type 2 Diabetes Mellitus: Metabolic Links and Therapeutic Considerations

Sample size: 1000000 publication Evidence: moderate

Author Information

Author(s): Sun Grace, Kashyap Sangeeta R.

Primary Institution: Cleveland Clinic

Hypothesis

Can mechanisms related to diabetes development predispose to oncogenic expression?

Conclusion

Type 2 diabetes mellitus increases the risk of certain cancers, including breast, endometrial, and colorectal cancers.

Supporting Evidence

  • Diabetes has been recognized as a key factor contributing to the development of solid organ malignancies.
  • Studies show that tobacco and excess alcohol usage linked to cancer can also worsen diabetes complications.
  • A recent meta-analysis indicated a 41% increase in cancer mortality related to endometrial, breast, and colorectal cancer in patients with preexisting diabetes.

Takeaway

People with type 2 diabetes have a higher chance of getting certain types of cancer, and treating diabetes better might help lower that risk.

Methodology

The paper reviews various studies linking diabetes and cancer, exploring metabolic pathways and therapeutic considerations.

Potential Biases

Potential biases due to reliance on observational studies and self-reported data.

Limitations

Many studies are retrospective and rely on self-reported data regarding diabetes diagnosis.

Participant Demographics

The study discusses demographics including age, sex, and race/ethnicity, particularly noting higher risks in older adults and African-Americans.

Digital Object Identifier (DOI)

10.1155/2011/708183

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication